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Summary
Nephrolithiasis is a multifactorial disease the genesis of which
is influenced by genetic, metabolic and environmental factors
which determine a series of alterations in the urinary excretion
of a number of substances, the cause of the disease itself. The
general practitioner is often the first professional to be consult-
ed as regards clinical and therapeutic treatment at the moment
of the onset of nephrolithiasis, renal colic, inasmuch as con-
tacted directly by the patient. His role however should not be
limited to this initial phase but becomes of strategic importance
throughout the subsequent diagnostic procedure; this is espe-
cially true with regard to relapses, in correctly placing the pa-
tient and, if necessary, referring him/her to the most appropri-
ate specialist area. Running through the entire process which
the lithiasic patient encounters from the onset of the disease
until therapeutic treatment begins, it is clear how an appropri-
ate initial approach can, in many cases, simplify and optimise
such process. On the basis therefore of a complete medical
record, and a few simple, biochemical and instrumental tests,
the general practitioner is in a position to decide whether to
treat the patient directly or to refer him/her to the most appro-
priate specialist field for investigation at a higher level.
Over the last decades nephrolithiasis has progressively
changed from being a disease of mainly surgical pertinence to
being one of multidisciplinary medical interest in which the
figure of the General Practitioner has a primary role, both dur-
ing the initial diagnostic phase, by means of the correct
physio-pathological identification of the problem, and in the
subsequent phases as regards the choice and co-ordination
of the various specialists involved.
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Nephrolithiasis is a disease with a strong epidemiological im-
pact known of since ancient times; even though comprehen-
sive data is not available, it is estimated that it has an inci-
dence, constantly on the increase in industrialised countries,
between 5% and 10% of the general population (1-10). For
many years the disease was of strictly surgical pertinence and
the surgical approach has made significant progress over the
last three decades; in fact the modern extra-corporeal and en-
doscopic methods of removing calculi have, in most cases, re-
placed the traditional surgical procedure (11-13). Still today
however, the surgical approach to the disease has the draw-
backs of not being entirely risk-free, not always being applica-
ble and not affecting the probability of relapses (14-16). Over
the same years the perfecting of laboratory techniques and the
increased knowledge of pathophysiology have opened the way
for a medical approach to the kidney stone disease which com-
plements and integrates the surgical approach; in fact a series
of anomalies of a metabolic or other nature origin, in turn re-
sulting from an interaction of genetic and environmental fac-
tors, have been progressively identified which facilitate the on-
set of the disease and the correction of which modifies the
prognosis (17-35). In other words the kidney behaves like a
homeostatic organ which responds efficiently to a metabolic in-
sult by correcting it, to the detriment of the upheaval of the uri-
nary environment which is thus exposed to a lithogenic risk
through the imbalance of over-saturation and inhibition. The
identification and treatment of such anomalies is the purpose of
the diagnostic-therapeutic process of medical pertinence, or-
ganised at various levels of diverse complexity in relation to the
type of calculosis present and to the degree of activity of the
disease (36).
The transit of the calculus along the urinary tract is often the
first clinical sign of renal stone disease. Initial intervention is
usually by the general practitioner or emergency services doc-
tor (37); subsequent management of the disease is then taken
over by the urologist with non-invasive or semi-invasive proce-
dures which permit resolution of the contingent problem in over
90% of cases. After the surgical phase an appropriate metabol-
ic assessment of the patient means that the pathogenesis of
the nephrolithiasis can be investigated and the dietary-pharma-
cological measures identified to resolve the clinical manifesta-
tions. 
The multidisciplinary nature of the approach to the patient af-
fected by renal stone disease with the consequent risk of frag-
mentary intervention and the absence of a systematic ap-
proach thus emerges (38). 
The general practitioner is often involved in dealing with a dis-
ease which has come to his/her knowledge in varying circum-
stances: because called in directly during a renal colic or as a
result of echography and/or X-rays performed on account of
the presence or suspicion of other diseases or simply as the
conclusion of an anamnesis (38).
The purpose of this study is to focus on the instruments avail-
able to the general practitioner through which he/she can per-
form a clearly-defined role in the diagnostic-therapeutic
process of nephrolithiasis.
The general practitioner is often the first professional figure in-
volved at the moment of the onset of the disease: renal colic.
This is an acute clinical phase caused by the engagement of
the calculus in the excretory tract, characterised by the onset of
a violent visceral pain with cramps at the side of the body, with
more or less extensive anterior irradiation as far as the hy-
pogastric-inguinal region as a result of the varying section of
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the ureter affected. It is often associated with neuro-vegetative
symptoms such as nausea, vomit, sweating and micro/macro-
hematuria. Faced with the presence of renal colic the approach
of the general practitioner must be focused, first of all, on ex-
cluding emergencies of a surgical nature (appendicitis, extra-
uterine pregnancy, ruptured aneurysm, perforated ulcer, etc.),
by means of patient’s case-history, a physical examination
(tenderness at the costal-vertebral angle on tapping or in the
lower quadrant of the abdomen), the presence or not of mi-
cro/macro-hematuria. Subsequently treatment must be begun
which aims at achieving three basic objectives: treatment of the
pain, removal of the calculus, safeguarding of renal function. 
The administration of an antispastic drug is a therapeutic
choice which is only partially adequate for treating the pain; in
fact this category of drugs acts exclusively on the spasm com-
ponent of the pain, which is not the only algogenic cause, and
which at the same time may prevent the progression of the cal-
culus by altering uretheral motility and therefore its sponta-
neous expulsion. For the treatment of pain in the first place, the
administration of NSAIDs appears more appropriate and sec-
ondly of opiates.
The role of NSAIDs in particular is of considerable impor-
tance during the first phase of the natural progress of renal
colic, in that these drugs block the events induced by the
prostaglandins, such as the vasodilation of the afferent arteri-
ole, thus reducing diuresis and consequently the intracavitary
pressure; in addition by reducing the oedema and inflammation
too, they lead to an attenuation of the painful symptoms and
favour the progression of the calculus; the duration of their use
is subordinate to the side-effects which they may produce on
the gastroenteric tract and renal perfusion. The use of opiates
is recommended when the effect of NSAIDs on the pain proves
insufficient.
While treatment of the painful symptoms is almost always ef-
fective the expulsive aspect is much more complicated. The
factors influencing expulsion of the calculus are basically the
size and the location but the type of calculus and the compli-
ance of the excretory tract also play their part. Knowing the lo-
cation may be important for choosing appropriate treatment, as
in the case in which the calculus is near the urethra-bladder
junction: by associating an alpha-lithic drug with the NSAIDs
the urethral muscles are relaxed, facilitating emission. Drinking
liquids does not seem to affect the progress of the colic, even
though an increase in diuresis may facilitate the progression of
the calculus in cases where the obstruction is not total and the
pain can be controlled pharmacologically (39-50).
By means of the anamnesis and clinical semiotics it is often
possible to predict the location of the calculus and identify
those situations in which the patient must be promptly sent to
hospital, as in the case of a bilateral obstruction, an infected
obstruction or pain which resists treatment. 
The anamnesis also enables the general practitioner to gather
information about family history of the disease and to assess
the importance of genetic and/or environmental factors which
may have determined it. By means of the anamnesis it is also
possible to determine the degree of activity of the disease
which in some cases presents itself as episodic and in others
as seriously recurrent. Such information gives the general
practitioner an idea of the degree of urgency with which to
send the patient for a specialist examination.
Once past the acute phase, for an optimal clinical picture it is
advisable to perform an echography of the urinary tract and a
direct X-ray of the abdomen. In almost all cases the perfor-
mance of these two test enables the general practitioner to
confirm the diagnosis and obtain information about the nature
of the calculi present on the basis of their radio-opacity or ra-
dio-transparency; it also permits the identification of calculi
along the excretory tract, a case requiring prompt urological in-
tervention since even the recovery of an asymptomatic condi-
tion after the colic does not exclude the occurrence of underly-
ing uropathies, which may be severe (51). 
The decision as to study all patients affected by nephrolithiasis
from a metabolical point of view or whether to reserve such as-
sessment only to patients with recurrent calculosis is still a
matter of debate. There are in fact studies which show how pa-
tients suffering their first episode of the disease have the same
incidence and severity of metabolic alterations as patients with
recurrent nephrolithiasis; the first renal calculus could more-
over be the first clinical sign of a systemic disease, asympto-
matic until such moment, such as renal tubular acidosis (52-55)
or hyper-parathyroidism (56, 57). At the Consensus Confer-
ence of the National Institutes of Health on the Prevention and
Treatment of Renal Calculi (58) it was in fact decided that all
patients, including those suffering their first episode of
nephrolithiasis, should undergo first level metabolic assess-
ment. On the other hand, a complete metabolic study per-
formed on the total population of lithiasic patients, even at their
first episode, is not always feasible for reasons of cost and pa-
tient compliance. It is here that the importance of a metabolic
assessment at various levels, of the patient affected by
nephrolithiasis comes into play, based on the number of calculi
present and the number of relapses. Within the sphere of this
context, it is the task of the general practitioner to make a pri-
mary assessment of the patient by means of blood tests and
urine tests, simple to perform and low in cost (Table I), aimed
at confirming the diagnosis, excluding the main causes of sec-
ondary renal calculosis and deciding whether or not to send the
patient for further specialist advice. 
In fact one of the essential tasks of the general practitioner is
that of making an initial distinction between primary idiopathic
calculosis, of strictly nephrological competence, and secondary
calculosis.
Table I - The patient affected by renal calculosis in the General
Practitioner’s setting: first-level biochemical framework.
Renal function: creatininaemia, azotemia, complete urine tests,
urine culture
Metabolic profile: glycemia, uricemia, lipid profile
Plasmatic electrolytes: sodium, potassium, chloride, calcium, 
phosphorus
Analysis of the calculus expelled (semi-quantitative method)
The assessment of any reduction of renal function in the sub-
ject affected by nephrolithiasis is important because the calcu-
losis may be the cause; but on the other hand the deficit of
concentration accompanying the reduction of the filtrate may
result in an improvement of a previously active nephrolithiasis. 
The assay of the humoral parameters relative to the glycolipid
metabolism means that diseases such as metabolic syndrome
and overweight, factors potentially favouring the presence of
nephrolithiasis, may be investigated (59-69).
The assay of the plasmatic uric acid is justified by the fact that
an increase in its haematic share may predispose to calculosis
by increasing its urinary excretion (34-36).
The determination of calcium and phosphorus permits the ex-
clusion, in almost all cases, of the presence of primitive hyper-
para-thyroidism: a pathological condition of which nephrolithia-
sis may be the only clinical sign present at its onset (70). The
assay of the plasmatic electrolytes permits investigation of clin-
ical conditions such as hyperaldosteronism or other states of
hypopotassiemia: electrolytic disorders responsible for an al-
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tered equilibrium between the urinary excretion of calcium and
citrate. The correct performance of a standard urine test and
urine culture also permits the exclusion of infections of the uri-
nary tract as the possible cause of secondary calculosis (71-
73) and provides important information on the nature of the cal-
culosis by observing the type of crystalluria present in the sedi-
ment. Lastly, the chemical analysis of the calculi expelled (to
be performed using high-precision, reliable methods, such as
infrared spectrophotometry) enables determination of the com-
position, an important starting point facilitating the metabolic
study of the subsequent level and of specialistic pertinence. 
A so-called, first-level screening performed by the general
practitioner must therefore consist of a general look at the pa-
tient, starting from the calculosis event and from what might be
correlated to it. 
The task of the general practitioner should not be limited to this
first phase but remains extremely important during the subse-
quent diagnostic-therapeutic course of the lithiasic disease, to
verify compliance with dietetic-pharmacological prescriptions
and to monitor any relapses, since, as we know, nephrolithiasis
may worsen over time with total absence of symptoms, some-
times with serious and irreversible effects on kidney function. 
A useful contribution to the study of nephrolithiasis could come
from the involvement of general practitioners in research of an
epidemiological nature. He/she being the most appropriate pro-
fessional figure for conducting this type of investigation, given
his/her unique relationship of trust established with a definite
number of patients.
Over the last decades nephrolithiasis has progressively
changed from being a disease of mainly surgical pertinence to
being one of multidisciplinary medical interest often requiring
the intervention of various professional figures, each with their
own specialistic expertise. Using the simple but effective instru-
ments at his disposal the general practitioner can play a strate-
gic role in simplifying and optimising the diagnostic-therapeutic
course of the disease.
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